The Ozempic lawsuit centers on allegations that Novo Nordisk failed to adequately warn consumers about serious risks associated with Ozempic and other GLP-1 medications
TRIUMPH-6 studies obstructive sleep apnea with concomitant obesity, a population already targeted by tirzepatide in SURMOUNT-OSA
Here's what to know GLP-1 Pills Are On The Way
Stefan N, Ramsauer M, Jordan P et al (2014) Inhibition of 11beta-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Aftermath If taken, users may notice: Minimal or no weight loss No medical supervision Potential side effects Difficulty canceling auto-pay or requesting refunds Lay users may feel misledtricked into thinking they were receiving a legitimate pharmaceutical treatment
Elevated inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6) predict cardiovascular events independent of traditional risk factors like cholesterol and blood pressure